| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9522 |
| Human Intestinal Absorption | HIA+ | 0.9734 |
| Caco-2 Permeability | Caco2- | 0.5545 |
| P-glycoprotein Substrate | Non-substrate | 0.7504 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8192 |
| Non-inhibitor | 0.9941 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9123 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7688 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8171 |
| CYP450 2D6 Substrate | Non-substrate | 0.7389 |
| CYP450 3A4 Substrate | Substrate | 0.5239 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6184 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7083 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9249 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6519 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6149 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8909 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9578 |
| Non-inhibitor | 0.9468 |
| AMES Toxicity | AMES toxic | 0.7733 |
| Carcinogens | Non-carcinogens | 0.8077 |
| Fish Toxicity | Low FHMT | 0.7019 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8684 |
| Honey Bee Toxicity | High HBT | 0.7413 |
| Biodegradation | Not ready biodegradable | 0.7770 |
| Acute Oral Toxicity | II | 0.4387 |
| Carcinogenicity (Three-class) | Non-required | 0.6142 |